4.2.3.123: beta-sesquiphellandrene synthase
This is an abbreviated version!
For detailed information about beta-sesquiphellandrene synthase, go to the full flat file.
Reaction
Synonyms
Os08g07100, PmSTS, STS, TPS1
ECTree
Advanced search results
Engineering
Engineering on EC 4.2.3.123 - beta-sesquiphellandrene synthase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
L405V
products are 1.9% 7-epi-sesquithujene, 8.1% (E)-alpha-bergamotene, 8.9% sesquiabinene A, 23.9% (E)-beta-farnesene, 0% gamma-curcumene, 9.7% zingiberene, 12.0% beta-bisabolene, 26.6% beta-sesquiphellandrene, 8.9% (E)-gamma-bisabolene
L405V/Y373S
products are 1.2% 7-epi-sesquithujene, 23.6% (E)-alpha-bergamotene, 17.7% sesquiabinene A, 53.0% (E)-beta-farnesene, 0% gamma-curcumene, 0.6% zingiberene, 1.3% beta-bisabolene, 2.6% beta-sesquiphellandrene, 0% (E)-gamma-bisabolene
Y373S
products are 7.6% 7-epi-sesquithujene, 24.8% (E)-alpha-bergamotene, 18.2% sesquiabinene A, 38.5% (E)-beta-farnesene, 0% gamma-curcumene, 4.7% zingiberene, 2.5% beta-bisabolene, 3.7% beta-sesquiphellandrene, 0% (E)-gamma-bisabolene
L401V
products are 0.4% 7-epi-sesquithujene, 0.7% (E)-alpha-bergamotene, 1.5% sesquiabinene A, 6.2% (E)-beta-farnesene, 0% gamma-curcumene, 8.4% zingiberene, 9.5% beta-bisabolene, 73.3% beta-sesquiphellandrene
L401V/V435S
products 1.3% 7-epi-sesquithujene, 0% (E)-alpha-bergamotene, 2.1% sesquiabinene A, 17.6% (E)-beta-farnesene, 0% gamma-curcumene, 5.8% zingiberene, 30.6% beta-bisabolene, 42.6% beta-sesquiphellandrene
L405L
products are 0.9% 7-epi-sesquithujene, 1.1% (E)-alpha-bergamotene, 0.6% sesquiabinene A, 3.3% (E)-beta-farnesene, 0% gamma-curcumene, 37.5% zingiberene, 7.6% beta-bisabolene, 49.0% beta-sesquiphellandrene
V435S
products are 2.2% 7-epi-sesquithujene, 0% (E)-alpha-bergamotene, 1.7% sesquiabinene A, 5% (E)-beta-farnesene, 0% gamma-curcumene, 17.8% zingiberene, 32.3% beta-bisabolene, 41% beta-sesquiphellandrene
Y369S
products are 1.1% 7-epi-sesquithujene, 0.7% (E)-alpha-bergamotene, 1.3% sesquiabinene A, 48.4% (E)-beta-farnesene, 0.4% gamma-curcumene, 44.8% zingiberene, 1.3% beta-bisabolene, 2.0% beta-sesquiphellandrene
Y369S /V435S
products are 2.5% 7-epi-sesquithujene, 2.9% (E)-alpha-bergamotene, 3.8% sesquiabinene A, 29.6% (E)-beta-farnesene, 0% gamma-curcumene, 18.6% zingiberene, 17.9% beta-bisabolene, 24.7% beta-sesquiphellandrene
Y369S/L401V
products are 2.0% 7-epi-sesquithujene, 11.4% (E)-alpha-bergamotene, 17.6% sesquiabinene A, 29.6% (E)-beta-farnesene, 4.9% gamma-curcumene, 8.2% zingiberene, 6.3% beta-bisabolene, 20% beta-sesquiphellandrene
Y369S/L401V/V435S
products are 2.0% 7-epi-sesquithujene, 6.2% (E)-alpha-bergamotene, 10.1% sesquiabinene A, 36.6% (E)-beta-farnesene, 0% gamma-curcumene, 8.2% zingiberene, 12.6% beta-bisabolene, 24.3% beta-sesquiphellandrene
Y373S
products are 3.3% 7-epi-sesquithujene, 15.6% (E)-alpha-bergamotene, 10.6% sesquiabinene A, 38.9% (E)-beta-farnesene, 0.0% gamma-curcumene, 9.8% zingiberene, 5.0% beta-bisabolene, 16.8% beta-sesquiphellandrene
additional information
N-terminal truncation, resulting in mutant PmSTS_DELTA124, does not affect the enzyme activity of PmSTS
additional information
-
N-terminal truncation, resulting in mutant PmSTS_DELTA124, does not affect the enzyme activity of PmSTS